EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens

Christian Shleider Carnero Canales iD, Cesar Augusto Roque-Borda iD, Jessica Ingrid Marquez Cazorla iD, Renzo Marianito Marquez Cazorla iD, Uner Josseph Pinto Apaza iD, Vanderson de Jesus Silva iD, Laura Maria Duran Gleriani Primo iD, Maura Jennifer Martínez-Morales iD, Rafael Miguel Sábio iD, Hélder A Santos iD, Fernando Rogério Pavan iD

Small · 2025-07 · 21 (26)

DOI: 10.1002/smll.202501431 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 19.05.2025. Verfasst von Christian Shleider Carnero Canales und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vicerrectorado de Investigación, Universidad Autónoma del Perú, Lima, 150142, Perú. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Nanotechnology, Gastrointestinal Tract. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 274 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Productivity Research Fellows (PQ CNPq), UMCG Research Funds, São Paulo Research Foundation (FAPESP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal infections, which are caused primarily by pathogenic bacteria, remain a significant global health challenge. Their resilience is reinforced by various physical, biological, and biopharmaceutical barriers that complicate conventional therapeutic strategies. This review delves into the intricate landscape of managing these infections, addressing microbiota imbalances, the emergence of multidrug‐resistant strains, and the impact of dysbiosis and antibiotic overuse. Faced with these challenges, traditional therapies often fail, which is hindered by low bioavailability, prolonged regimens, and a growing risk of resistance. In this context, nanotechnology applied to antimicrobial peptides (AMPs) has emerged as a promising solution to enhance their stability and targeted delivery. Through a critical approach, diverse nanocarriers and their efficacy against intestinal pathogens are evaluated both in vitro and in vivo. This review advocates for intensified research on the encapsulation and functionalization of AMPs, envisioning their potential to redefine the control of intestinal infections on a global scale.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial PeptidesNanotechnologyGastrointestinal TractHumansAnimals

Stichwörter der Autor:innen

antimicrobial peptidegastrointestinal infectionsmultidrug resistancenanocarriersnanoparticles

Substanzen

Antimicrobial Peptides

Autor:innen und Institutionen

  • Vicerrectorado de Investigación, Universidad Autónoma del Perú, Lima, 150142, Perú.
  • School of Pharmacy, Biochemistry and Biotechnology, Santa Maria Catholic University (UCSM), Arequipa, 04013, Perú.
  • Tuberculosis Research Laboratory, School of Pharmaceutical Science, São Paulo State University (UNESP), Araraquara, 14800-903, Brazil.
  • Laboratoire de Chimie des Polymères Organiques, Université de Bordeaux, Bordeaux, 33000, France.
  • Department of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), University Medical Center Groningen, University of Groningen, Groningen, 9713 AV, The Netherlands.

ORCID-Profile: Christian Shleider Carnero Canales, Cesar Augusto Roque-Borda, Jessica Ingrid Marquez Cazorla, Renzo Marianito Marquez Cazorla, Uner Josseph Pinto Apaza, Vanderson de Jesus Silva, Laura Maria Duran Gleriani Primo, Maura Jennifer Martínez-Morales, Rafael Miguel Sábio, Hélder A Santos, Fernando Rogério Pavan

Förderung

  • Productivity Research Fellows (PQ CNPq)
  • UMCG Research Funds
  • São Paulo Research Foundation (FAPESP)

Zitieren

APA

Carnero Canales, C. S., Roque-Borda, C. A., Cazorla, J. I. M., Cazorla, R. M. M., Apaza, U. J. P., Silva, V. J., Primo, L. M. D. G., Martínez-Morales, M. J., Miguel Sábio, R., Santos, H. A., & Pavan, F. R. (2025). Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens. Small, 21(26). https://doi.org/10.1002/smll.202501431

Vancouver

Carnero Canales CS, Roque-Borda CA, Cazorla JIM, Cazorla RMM, Apaza UJP, Silva VJ, et al. Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens. Small. 2025;21(26). doi:10.1002/smll.202501431

BibTeX
@article{CarneroCanales2025,
  author = {Carnero Canales, Christian Shleider and Roque-Borda, Cesar Augusto and Cazorla, Jessica Ingrid Marquez and Cazorla, Renzo Marianito Marquez and Apaza, Uner Josseph Pinto and Silva, Vanderson de Jesus and Primo, Laura Maria Duran Gleriani and Martínez-Morales, Maura Jennifer and Miguel Sábio, Rafael and Santos, Hélder A and Pavan, Fernando Rogério},
  title = {Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {26},
  doi = {10.1002/smll.202501431}
}
Kostenlos starten →